Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35


Longitudinal serological measures of common infection in the Avon Longitudinal Study of Parents and Children cohort.

Mitchell RE, Jones HJ, Yolken RH, Ford G, Jones-Brando L, Ring SM, Groom A, FitzGibbon S, Davey Smith G, Timpson NJ.

Version 2. Wellcome Open Res. 2018 Jul 23 [revised 2018 Jan 1];3:49. doi: 10.12688/wellcomeopenres.14565.2. eCollection 2018.


Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus.

Dickerson F, Jones-Brando L, Ford G, Genovese G, Stallings C, Origoni A, O'Dushlaine C, Katsafanas E, Sweeney K, Khushalani S, Yolken R.

Schizophr Bull. 2018 Nov 20. doi: 10.1093/schbul/sby164. [Epub ahead of print]


Aggression, impulsivity and inflammatory markers as risk factors for suicidal behavior.

Coryell W, Wilcox H, Evans SJ, Pandey GN, Jones-Brando L, Dickerson F, Yolken R.

J Psychiatr Res. 2018 Nov;106:38-42. doi: 10.1016/j.jpsychires.2018.09.004. Epub 2018 Sep 11.


Host-parasite interaction associated with major mental illness.

Kano SI, Hodgkinson CA, Jones-Brando L, Eastwood S, Ishizuka K, Niwa M, Choi EY, Chang DJ, Chen Y, Velivela SD, Leister F, Wood J, Chowdari K, Ducci F, Caycedo DA, Heinz E, Newman ER, Cascella N, Mortensen PB, Zandi PP, Dickerson F, Nimgaonkar V, Goldman D, Harrison PJ, Yolken RH, Sawa A.

Mol Psychiatry. 2018 Aug 20. doi: 10.1038/s41380-018-0217-z. [Epub ahead of print]


One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii.

Brown CE, Kong T, Bordón C, Yolken R, Jones-Brando L, McNulty J.

Bioorg Med Chem Lett. 2018 May 15;28(9):1642-1646. doi: 10.1016/j.bmcl.2018.03.036. Epub 2018 Mar 16.


AAH2 gene is not required for dopamine-dependent neurochemical and behavioral abnormalities produced by Toxoplasma infection in mouse.

McFarland R, Wang ZT, Jouroukhin Y, Li Y, Mychko O, Coppens I, Xiao J, Jones-Brando L, Yolken RH, Sibley LD, Pletnikov MV.

Behav Brain Res. 2018 Jul 16;347:193-200. doi: 10.1016/j.bbr.2018.03.023. Epub 2018 Mar 16.


Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives.

Carradori S, Secci D, Bizzarri B, Chimenti P, De Monte C, Guglielmi P, Campestre C, Rivanera D, Bordón C, Jones-Brando L.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):746-758. doi: 10.1080/14756366.2017.1316494.


Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Severance EG, Xiao J, Jones-Brando L, Sabunciyan S, Li Y, Pletnikov M, Prandovszky E, Yolken R.

Int Rev Neurobiol. 2016;131:143-163. doi: 10.1016/bs.irn.2016.08.008. Epub 2016 Oct 4. Review.


Enol ethers as carbonyl surrogates in a modification of the Povarov synthesis of 3-aryl quinolines and their anti-Toxoplasma activity.

Brown CE, McNulty J, Bordón C, Yolken R, Jones-Brando L.

Org Biomol Chem. 2016 Jul 7;14(25):5951-5. doi: 10.1039/c6ob01083k. Epub 2016 Jun 3.


Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls.

Passeri E, Jones-Brando L, Bordón C, Sengupta S, Wilson AM, Primerano A, Rapoport JL, Ishizuka K, Kano S, Yolken RH, Sawa A.

Microbes Infect. 2016 Feb;18(2):153-8. doi: 10.1016/j.micinf.2015.09.023. Epub 2015 Oct 9.


Synthesis of the cyanobacterial metabolite nostodione A, structural studies and potent antiparasitic activity against Toxoplasma gondii.

McNulty J, Keskar K, Jenkins HA, Werstiuk NH, Bordón C, Yolken R, Jones-Brando L.

Org Biomol Chem. 2015 Oct 21;13(39):10015-24. doi: 10.1039/c5ob01506e.


Reply to Kjartansdóttir et al.: Chlorovirus ATCV-1 findings not explained by contamination.

Yolken RH, Jones-Brando L, Dunigan DD, Kannan G, Dickerson F, Severance E, Sabunciyan S, Talbot CC Jr, Prandovszky E, Gurnon JR, Agarkova IV, Leister F, Gressitt KL, Chen O, Deuber B, Ma F, Pletnikov MV, Van Etten JL.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):E927. doi: 10.1073/pnas.1424665112. Epub 2015 Feb 5. No abstract available.


Chlorovirus ATCV-1 is part of the human oropharyngeal virome and is associated with changes in cognitive functions in humans and mice.

Yolken RH, Jones-Brando L, Dunigan DD, Kannan G, Dickerson F, Severance E, Sabunciyan S, Talbot CC Jr, Prandovszky E, Gurnon JR, Agarkova IV, Leister F, Gressitt KL, Chen O, Deuber B, Ma F, Pletnikov MV, Van Etten JL.

Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16106-11. doi: 10.1073/pnas.1418895111. Epub 2014 Oct 27.


Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii.

D'Ascenzio M, Bizzarri B, De Monte C, Carradori S, Bolasco A, Secci D, Rivanera D, Faulhaber N, Bordón C, Jones-Brando L.

Eur J Med Chem. 2014 Oct 30;86:17-30. doi: 10.1016/j.ejmech.2014.08.046. Epub 2014 Aug 15.


One minute ultraviolet exposure inhibits Toxoplasma gondii tachyzoite replication and cyst conversion without diminishing host humoral-mediated immune response.

Kannan G, Prandovszky E, Steinfeldt CB, Gressitt KL, Yang C, Yolken RH, Severance EG, Jones-Brando L, Pletnikov MV.

Exp Parasitol. 2014 Oct;145:110-7. doi: 10.1016/j.exppara.2014.08.001. Epub 2014 Aug 14.


Total synthesis of the cyanobacterial metabolite nostodione A: discovery of its antiparasitic activity against Toxoplasma gondii.

McNulty J, Keskar K, Bordón C, Yolken R, Jones-Brando L.

Chem Commun (Camb). 2014 Aug 18;50(64):8904-7. doi: 10.1039/c4cc03904a.


A thiazole derivative of artemisinin moderately reduces Toxoplasma gondii cyst burden in infected mice.

Schultz TL, Hencken CP, Woodard LE, Posner GH, Yolken RH, Jones-Brando L, Carruthers VB.

J Parasitol. 2014 Aug;100(4):516-21. doi: 10.1645/13-451.1. Epub 2014 Feb 13.


Transcriptional derepression of the ERVWE1 locus following influenza A virus infection.

Li F, Nellåker C, Sabunciyan S, Yolken RH, Jones-Brando L, Johansson AS, Owe-Larsson B, Karlsson H.

J Virol. 2014 Apr;88(8):4328-37. doi: 10.1128/JVI.03628-13. Epub 2014 Jan 29.


Synthesis and anti-toxoplasmosis activity of 4-arylquinoline-2-carboxylate derivatives.

McNulty J, Vemula R, Bordón C, Yolken R, Jones-Brando L.

Org Biomol Chem. 2014 Jan 14;12(2):255-60. doi: 10.1039/c3ob41539b.


Abnormalities of neurotransmitter and neuropeptide systems in human neuroepithelioma cells infected by three Toxoplasma strains.

Xiao J, Li Y, Jones-Brando L, Yolken RH.

J Neural Transm (Vienna). 2013 Dec;120(12):1631-9. doi: 10.1007/s00702-013-1064-3. Epub 2013 Jul 3.


Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis.

Doggett JS, Nilsen A, Forquer I, Wegmann KW, Jones-Brando L, Yolken RH, Bordón C, Charman SA, Katneni K, Schultz T, Burrows JN, Hinrichs DJ, Meunier B, Carruthers VB, Riscoe MK.

Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15936-41. Epub 2012 Sep 10.


Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice.

Xiao J, Kannan G, Jones-Brando L, Brannock C, Krasnova IN, Cadet JL, Pletnikov M, Yolken RH.

Neuroscience. 2012 Mar 29;206:39-48. doi: 10.1016/j.neuroscience.2011.12.051. Epub 2012 Jan 3.


Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells.

Xiao J, Jones-Brando L, Talbot CC Jr, Yolken RH.

Infect Immun. 2011 Mar;79(3):1363-73. doi: 10.1128/IAI.00947-10. Epub 2010 Dec 13.


Toxoplasma gondii strain-dependent effects on mouse behaviour.

Kannan G, Moldovan K, Xiao JC, Yolken RH, Jones-Brando L, Pletnikov MV.

Folia Parasitol (Praha). 2010 Jun;57(2):151-5.


Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.

Arav-Boger R, He R, Chiou CJ, Liu J, Woodard L, Rosenthal A, Jones-Brando L, Forman M, Posner G.

PLoS One. 2010 Apr 28;5(4):e10370. doi: 10.1371/journal.pone.0010370.


Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.

Hencken CP, Jones-Brando L, Bordón C, Stohler R, Mott BT, Yolken R, Posner GH, Woodard LE.

J Med Chem. 2010 May 13;53(9):3594-601. doi: 10.1021/jm901857d.


Synthesis and evaluation of 4-acyl-2-thiazolylhydrazone derivatives for anti-Toxoplasma efficacy in vitro.

Chimenti F, Bizzarri B, Bolasco A, Secci D, Chimenti P, Carradori S, Granese A, Rivanera D, Frishberg N, Bordón C, Jones-Brando L.

J Med Chem. 2009 Aug 13;52(15):4574-7. doi: 10.1021/jm9005862.


Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.

D'Angelo JG, Bordón C, Posner GH, Yolken R, Jones-Brando L.

J Antimicrob Chemother. 2009 Jan;63(1):146-50. doi: 10.1093/jac/dkn451. Epub 2008 Nov 6.


Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.

Krivogorsky B, Grundt P, Yolken R, Jones-Brando L.

Antimicrob Agents Chemother. 2008 Dec;52(12):4466-9. doi: 10.1128/AAC.00903-08. Epub 2008 Sep 29.


In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin.

Jones-Brando L, D'Angelo J, Posner GH, Yolken R.

Antimicrob Agents Chemother. 2006 Dec;50(12):4206-8. Epub 2006 Oct 23.


Altered transcriptional activity of human endogenous retroviruses in neuroepithelial cells after infection with Toxoplasma gondii.

Frank O, Jones-Brando L, Leib-Mosch C, Yolken R, Seifarth W.

J Infect Dis. 2006 Nov 15;194(10):1447-9. Epub 2006 Oct 10.


Transactivation of elements in the human endogenous retrovirus W family by viral infection.

Nellåker C, Yao Y, Jones-Brando L, Mallet F, Yolken RH, Karlsson H.

Retrovirology. 2006 Jul 6;3:44.


Infectious pathogen detection arrays: viral detection in cell lines and postmortem brain tissue.

Conejero-Goldberg C, Wang E, Yi C, Goldberg TE, Jones-Brando L, Marincola FM, Webster MJ, Torrey EF.

Biotechniques. 2005 Nov;39(5):741-51.


Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii.

Jones-Brando L, Torrey EF, Yolken R.

Schizophr Res. 2003 Aug 1;62(3):237-44.


Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1.

Jones-Brando LV, Buthod JL, Holland LE, Yolken RH, Torrey EF.

Schizophr Res. 1997 May 3;25(1):63-70.


Supplemental Content

Loading ...
Support Center